Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Condition(s):Adult Brain TumorsLast Updated:June 4, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Adult Brain TumorsLast Updated:June 4, 2013Terminated
Condition(s):Brain Tumor – Metastatic; Brain Tumor, Adult: GlioblastomaLast Updated:March 19, 2020Unknown status
Condition(s):Recurrent Adult Brain TumorLast Updated:July 10, 2014Completed
Condition(s):Brain Tumor AdultLast Updated:May 16, 2023Recruiting
Condition(s):Brain Tumor AdultLast Updated:January 24, 2024Active, not recruiting
Condition(s):Brain Tumor AdultLast Updated:February 6, 2024Recruiting
Condition(s):Adult Brain TumorLast Updated:June 1, 2023Recruiting
Condition(s):Brain Tumor AdultLast Updated:January 10, 2024Recruiting
Condition(s):Adult Brain TumorLast Updated:March 13, 2019Completed
Condition(s):Brain Tumor AdultLast Updated:October 2, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.